Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Our investments in drug development companies like Charles River Labs (CRL) and Medpace Holdings (MEDP) pulled back, driven by AI disruption fears. Our work suggests...
— John Brown, Drew Justman
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. ($CRL), representing 3.4% of the composite, provides early-stage contract research services, animal models, and clinical discovery support for global pharmaceutical and biotechnology corporations. Ariel maintains a...
Charles River Laboratories ($CRL) provides essential preclinical laboratory testing, animal models, and drug discovery research services to biotechnology and pharmaceutical firms, accounting for 4.6% of fund assets. The manager maintains...
Charles River Laboratories ($CRL), which represents 3.9% of the fund's portfolio, is an essential contract research organization providing discovery and safety assessment services, laboratory products, and manufacturing support to the global biopharmaceutical industry. The manager holds...
More institutional theses from Madison Dividend Income Fund
Matador Resources Company is a Delaware Basin Exploration and Production (E&P) company founded in 2003.
ICU Medical is a medical device company that specializes in infusion therapy, vascular access, and vital care applications.
We initiated a new investment position in specialty distributor SiteOne Landscape Supply, the largest and only scaled consolidator in the landscape supply industry.